MAPK8 and glaucoma: Furthermore, even if the presence of glaucoma caused damage to the retinal tissue, the response to the pre- and post-treatment with VGLCR can significantly activate the cell survival mechanisms in the early phase of the disease, by reducing the activation of p38, MAPK, and JNK.